Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine plus nalbuphine versus bupivacaine alone for PECS I block after breast fibroadenoma excision
PACTR202112778684666Completed
- Sponsor
- Department of Anaesthesia, ICU and Pain Medicine, Ain Shams University
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of bupivacaine and nalbuphine in postoperative pain (2 arms), sponsored by Department of Anaesthesia, ICU and Pain Medicine, Ain Shams University. Primary endpoint: Visual Analog Scale pain score. Started Apr 2021; status: completed.
02
Drugs
bupivacainenalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202112778684666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112778684666.